Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Breast Cancer
Interventions
OTHER

REASSURE

REASSURE is comprised of three components that are intended to be integrated into survivorship care at each follow-up visit: 1) An online patient-reported outcome (PRO) assessment to comprehensively evaluate survivors' symptoms and concerns; 2) A tailored follow-up recommendation based on pre-established thresholds for reported symptoms and concerns. Survivors who report symptoms or concerns have a follow-up visit to discuss findings whereas survivors without symptoms or concerns will avoid a follow-up visit; and 3) Online survivorship messaging sent after the visit, which includes reassurance about the low recurrence risk, an overview of what to expect from follow-up, and steps survivors can take to reduce cancer risk.

Trial Locations (1)

53792

UW Health Oncology Clinics, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER